Related Articles
Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
Role of Wnt/β‑catenin, Wnt/c‑Jun N‑terminal kinase and Wnt/Ca2+ pathways in cisplatin‑induced chemoresistance in ovarian cancer
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer
Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment
miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin